Genes and pathways involved in adult onset disorders featuring muscle mitochondrial DNA instability

International Journal of Molecular Sciences

Volumn 16, Issue 8, 2015, Pages 18054-18076

  Ahmed, Naghia ^a   Ronchi, Dario ^a   Comi, Giacomo Pietro ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Adult mitochondrial disorders; Mitochondrial myopathy; mtDNA maintenance; Multiple mtDNA deletions; Progressive external ophthalmoplegia

Indexed keywords

DEOXYGUANOSINE KINASE; MITOCHONDRIAL DNA; THYMIDINE PHOSPHORYLASE;

AEROBIC METABOLISM; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA REPAIR; ENZYME ACTIVITY; GENE MUTATION; GENE SEQUENCE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MITOCHONDRIAL DYNAMICS; NEXT GENERATION SEQUENCING; PHENOTYPE; REVIEW; ADULT; GENETICS; GENOMIC INSTABILITY; METABOLISM; MUSCLE; MUSCLE MITOCHONDRION; MUTATION; PATHOLOGY;

ADULT; DNA, MITOCHONDRIAL; GENOMIC INSTABILITY; HUMANS; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL DISEASES; MUSCLES; MUTATION;

EID: 84938827362     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160818054     Document Type: Review

References (117)

1. Schapira, A.H. Mitochondrial diseases. Lancet 2012, 379, 1825-1834.
2. Delonlay, P.; Rötig, A.; Sarnat, H.B. Respiratory chain deficiencies. Handb. Clin. Neurol. 2013, 113, 1651-1666.
3. Yu-Wai-Man, C.; Smith, F.E.; Firbank, M.J.; Guthrie, G.; Guthrie, S.; Gorman, G.S.; Taylor, R.W.; Turnbull, D.M.; Griffiths, P.G.; Blamire, A.M.; et al. Extraocular muscle atrophy and central nervous system involvement in chronic progressive external ophthalmoplegia. PLoS ONE 2013, 8, e75048, doi:10.1371/journal.pone.0075048.
4. Sundaram, C.; Meena, A.K.; Uppin, M.S.; Govindaraj, P.; Vanniarajan, A.; Thangaraj, K.; Kaul, S.; Kekunnaya, R.; Murthy, J.M. Contribution of muscle biopsy and genetics to the diagnosis of chronic progressive external opthalmoplegia of mitochondrial origin. J. Clin. Neurosci. 2011, 18, 535-538.
5. Wong, L.J.; Boles, R.G. Mitochondrial DNA analysis in clinical laboratory diagnostics. Clin. Chim. Acta 2005, 354, 1-20.
6. Zhang, C.; Baumer, A.; Maxwell, R.J.; Linnane, A.W.; Nagley, P. Multiple mitochondrial DNA deletions in an elderly human individual. FEBS 1992, 297, 34-38.
7. Kaukonen, J.; Juselius, J.K.; Tiranti, V.; Kyttälä, A.; Zeviani, M.; Comi, G.P.; Keränen, S.; Peltonen, L.; Suomalainen, A. Role of adenine nucleotide translocator 1 in mtDNA maintenaince. Science 2000, 289, 782-785.
8. Holt, I.J.; Reyes, A. Human mitochondrial DNA replication. Cold Spring Harb. Perspect. Biol. 2012, 4, doi:10.1101/cshperspect.a012971.
9. Finsterer, J.; Ahting, U. Mitochondrial depletion syndromes in children and adults. Can. J. Neurol. Sci. 2013, 40, 635-644.
10. Mitochondrial DNA Deletion Syndromes. Available online: http://www.ncbi.nlm.nih.gov/books/ NBK1203/PubMed PMID: 20301382 (accessed on 3 May 2011).
11. Spinazzola, A.; Zeviani, M. Mitochondrial diseases: A cross-talk between mitochondrial and nuclear genomes. Adv. Exp. Med. Biol. 2009, 652, 69-84.
12. Van Goethem, G.; Dermaut, B.; Löfgren, A.; Martin, J.J.; van Broeckhoven, C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat. Genet. 2001, 28, 211-212.
13. Longley, M.J.; Clark, S.; Yu, W.; Man, C.; Hudson, G.; Durham, S.E.; Taylor, R.W.; Nightingale, S.; Turnbull, D.M.; Copeland, W.C.; et al. Mutant POLG2 disrupts DNA polymerasegamma subunits and causes progressive external ophthalmoplegia. Am. J. Hum. Genet. 2006, 78, 1026-1034.
14. Spelbrink, J.N.; Li, F.Y.; Tiranti, V.; Nikali, K.; Yuan, Q.P.; Tariq, M.; Wanrooij, S.; Garrido, N.; Comi, G.; Morandi, L.; et al. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat. Genet. 2001, 28, 223-231.
15. Ronchi, D.; di Fonzo, A.; Lin, W.; Bordoni, A.; Liu, C.; Fassone, E.; Pagliarani, S.; Rizzuti, M.; Zheng, L.; Filosto, M.; et al. Mutations in DNA2 link progressive myopathy to mitochondrial DNA instability. Am. J. Hum. Genet. 2013, 92, 293-300.
16. Kornblum, C.; Nicholls, T.J.; Haack, T.B.; Schöler, S.; Peeva, V.; Danhauser, K.; Hallmann, K.; Zsurka, G.; Rorbach, J.; Iuso, A.; et al. Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease. Nat. Genet. 2013, 45, 214-249.
17. Nishino, I.; Spinazzola, A.; Papadimitriou, A.; Hammans, S.; Steiner, I.; Hahn, C.D.; Connolly, A.M.; Verloes, A.; Guimarães, J.; Maillard, I.; et al. Mitochondrial neurogastrointestinal encephalomyopathy: An autosomal recessive disorder due to thymidine phosphorylase mutations. Ann. Neurol. 2000, 47, 792-800.
18. Saada, A.; Shaag, A.; Mandel, H.; Nevo, Y.; Eriksson, S.; Elpeleg, O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat. Genet. 2001, 29, 342-344.
19. Mandel, H.; Szargel, R.; Labay, V.; Elpeleg, O.; Saada, A.; Shalata, A.; Anbinder, Y.; Berkowitz, D.; Hartman, C.; Barak, M.; et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat. Genet. 2001, 29, 337-341, Erratum in: Nat. Genet. 29 December 2001.
20. Bourdon, A.; Minai, L.; Serre, V.; Jais, J.P.; Sarzi, E.; Aubert, S.; Chrétien, D.; de Lonlay, P.; Paquis-Flucklinger, V.; Arakawa, H.; et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat. Genet. 2007, 39, 776-780.
21. Elpeleg, O.; Miller, C.; Hershkovitz, E.; Bitner-Glindzicz, M.; Bondi-Rubinstein, G.; Rahman, S.; Pagnamenta, A.; Eshhar, S.; Saada, A. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am. J. Hum. Genet. 2005, 76, 1081-1086.
22. Ostergaard, E.; Christensen, E.; Kristensen, E.; Mogensen, B.; Duno, M.; Shoubridge E.A.; Wibrand, F. Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am. J. Hum. Genet. 2007, 81, 383-387.
23. Besse, A.; Wu, P.; Bruni, F.; Donti, T.; Graham, B.H.; Craigen, W.J.; McFarland, R.; Moretti, P.; Lalani, S.; Scott K.L.; et al. The GABA transaminase, ABAT, is essential for mitochondrial nucleoside metabolism. Cell Metab. 2015, 21, 417-427.
24. Amati-Bonneau, P.; Valentino, M.L.; Reynier, P.; Gallardo, M.E.; Bornstein, B.; Boissière, A.; Campos, Y.; Rivera, H.; de la Aleja, J.G.; Carroccia, R.; et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy "plus" phenotypes. Brain 2008, 131, 338-351.
25. Rouzier, C.; Bannwarth, S.; Chaussenot, A.; Chevrollier, A.; Verschueren, A.; Bonello-Palot, N.; Fragaki, K.; Cano, A.; Pouget, J.; Pellissier, J.F.; et al. The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy "plus" phenotype. Brain 2012, 135, 23-34.
26. Bonnen, P.E.; Yarham, J.W.; Besse, A.; Wu, P.; Faqeih, E.A.; Al-Asmari, A.M.; Saleh, M.A.; Eyaid, W.; Hadeel, A.; He, L.; et al. Mutations in FBXL4 cause mitochondrial encephalopathy and a disorder of mitochondrial DNA maintenance. Am. J. Hum. Genet. 2003, 93, 471-481, Erratum in: Am. J. Hum. Genet. 2013, 93, 773.
27. Gai, X.; Ghezzi, D.; Johnson, M.A.; Biagosch, C.A.; Shamseldin, H.E.; Haack, T.B.; Reyes, A.; Tsukikawa, M.; Sheldon, C.A.; Srinivasan, S.; et al. Mutations in FBXL4, encoding a mitochondrial protein, cause early-onset mitochondrial encephalomyopathy. Am. J. Hum. Genet. 2013, 93, 482-495.
28. Ronchi, D.; Garone, C.; Bordoni, A.; Gutierrez Rios, P.; Calvo, S.E.; Ripolone, M.; Ranieri, M.; Rizzuti, M.; Villa, L.; Magri, F.; et al. Next-generation sequencing reveals DGUOK mutations in adult patients with mitochondrial DNA multiple deletions. Brain 2012, 135, 3404-3415.
29. Saada, A.; Shaag, A.; Elpeleg, O. mtDNA depletion myopathy: Elucidation of the tissue specificity in the mitochondrial thymidine kinase (TK2) deficiency. Mol. Genet. Metab. 2003, 79, 1-5.
30. Casari, G.; de Fusco, M.; Ciarmatori, S.; Zeviani, M.; Mora, M.; Fernandez, P.; de Michele, G.; Filla, A.; Cocozza, S.; Marconi, R.; et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998, 93, 973-983.
31. Klebe, S.; Depienne, C.; Gerber, S.; Challe, G.; Anheim, M.; Charles, P.; Fedirko, E.; Lejeune, E.; Cottineau, J.; Brusco, A.; et al. Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy. Brain 2012, 135, 2980-2993.
32. Pfeffer, G.; Gorman, G.S.; Griffin, H.; Kurzawa-Akanbi, M.; Blakely, E.L.; Wilson, I.; Sitarz, K.; Moore, D.; Murphy, J.L.; Alston, C.L.; et al. Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance. Brain 2014, 137, 1323-1336.
33. Bannwarth, S.; Ait-El-Mkadem, S.; Chaussenot, A.; Genin, E.C.; Lacas-Gervais, S.; Fragaki, K.; Berg-Alonso, L.; Yusuke Kageyama.; Serre, V.; Moore, D.G.; et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain 2014, 137, 2329-2345.
34. Ronchi, D.; Riboldi, G.; del Bo, R.; Ticozzi, N.; Scarlato, M.; Galimberti, D.; Corti, S.; Silani, V.; Bresolin, N.; Comi, G.P. CHCHD10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis. Brain 2015, doi:10.1093/brain/awu384.
35. Penttilä, S.; Jokela, M.; Bouquin, H.; Saukkonen, A.M.; Toivanen, J.; Udd, B. Late onset spinal motor neuronopathy is caused by mutation in CHCHD10. Ann. Neurol. 2015, 77, 163-172.
36. Ajroud-Driss, S.; Fecto, F.; Ajroud, K.; Lalani, I.; Calvo, S.E.; Mootha, V.K.; Deng, H.X.; Siddique, N.; Tahmoush, A.J.; Heiman-Patterson, T.D.; et al. Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy. Neurogenetics 2015, 16, 1-9.
37. Cogliati, S.; Frezza, C.; Soriano, M.E.; Varanita, T.; Quintana-Cabrera, R.; Corrado, M.; Cipolat, S.; Costa, V.; Casarin, A.; Gomes, L.C.; et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell 2013, 155, 160-171.
38. Wanrooij, S.; Falkenberg, M. The human mitochondrial replication fork in health and disease. Biochim. Biophys. Acta 2010, 1797, 1378-1388.
39. Spelbrink, J.N.; Toivonen, J.M.; Hakkaart, G.A.; Kurkela, J.M.; Cooper, H.M.; Lehtinen, S.K.; Lecrenier, N.; Back, J.W.; Speijer, D.; Foury, F.; et al. In vivo functional analysis of the human mitochondrial DNA polymerase POLG expressed in cultured human cells. J. Biol. Chem. 2000, 275, 24818-24828.
40. Graziewicz, M.A.; Longley, M.J.; Bienstock, R.J.; Zeviani, M.; Copeland, W.C. Structure-function defects of human mitochondrial DNA polymerase in autosomal dominant progressive external ophthalmoplegia. Nat. Struct. Mol. Biol. 2004, 11, 770-776.
41. Del Bo, R.; Bordoni, A.; Sciacco, M.; di Fonzo, A.; Galbiati, S.; Crimi, M.; Bresolin, N.; Comi, G.P. Remarkable infidelity of polymerase gammaA associated with mutations in POLG1 exonuclease domain. Neurology 2003, 61, 903-908.
42. Isohanni, P.; Hakonen, A.H.; Euro, L.; Paetau, I.; Linnankivi, T.; Liukkonen, E.; Wallden, T.; Luostarinen, L.; Valanne, L.; Paetau, A.; et al. POLG1 manifestations in childhood. Neurology 2011, 76, 811-815.
43. Van Goethem, G.; Martin, J.J.; van Broeckhoven, C. Progressive External Ophtalmoplegia characterized by multiple deletions of mitochondrial DNA. Neuromol. Med. 2003, 3, 129-146.
44. Delgado-Alvarado, M.; de la Riva, P.; Jiménez-Urbieta, H.; Gago, B.; Gabilondo, A.; Bornstein, B.; Rodríguez-Oroz, M.C. Parkinsonism, cognitive deficit and behavioural disturbance caused by a novel mutation in the polymerase gamma gene. J. Neurol. Sci. 2015, 350, 93-97.
45. Synofzik, M.; Srulijes, K.; Godau, J.; Berg, D.; Schöls, L. Characterizing POLG ataxia: Clinics, electrophysiology and imaging. Cerebellum 2012, 11, 1002-1011.
46. Mancuso, M.; Filosto, M.; Oh, S.J.; di Mauro, S. A novel polymerase gamma mutation in a family with ophthalmoplegia, neuropathy, and Parkinsonism. Arch. Neurol. 2004, 61, 1777-1779.
47. Davidzon, G.; Greene, P.; Mancuso, M.; Klos, K.J.; Ahlskog, J.E.; Hirano, M.; di Mauro, S. Early-onset familial parkinsonism due to POLG mutations. Ann. Neurol. 2006, 59, 859-862.
48. Luoma, P.; Melberg, A.; Rinne, J.O.; Kaukonen, J.A.; Nupponen, N.N.; Chalmers, R.M.; Oldfors, A.; Rautakorpi, I.; Peltonen, L.; Majamaa, K.; et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: Clinical and molecular genetic study. Lancet 2004, 364, 875-882.
49. Pagnamenta, A.T.; Taanman, J.W.; Wilson, C.J.; Anderson, N.E.; Marotta, R.; Duncan, A.J.; Bitner-Glindzicz, M.; Taylor, R.W.; Laskowski, A.; Thorburn, D.R.; et al. Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma. Hum. Reprod. 2006, 21, 2467-2473.
50. Neeve, V.C.M.; Samuels, D.C.; Bindoff, L.A.; van den Bosch, B.; van Goethem, G.; Smeet, H.; Lombès, A.; Jardel, C.; Hirano, M.; DiMauro, S.; et al. What is influencing the phenotype of the common homozygous polymerase γ mutation p.Ala467Thr? Brain 2012, 135, 3614-3626.
51. Stuart, G.R.; Santos, J.H.; Strand, M.K.; van Houten, B.; Copeland, W.C. Mitochondrial and nuclear DNA defects in Saccharomyces cerevisiae with mutations in DNA polymerase gamma associated with progressive external ophthalmoplegia. Hum. Mol. Genet. 2006, 15, 363-374.
52. Stumpf, J.D.; Bailey, C.M.; Spell, D.; Stillwagon, M.; Anderson, K.S.; Copeland, W.C. mip1 containing mutations associated with mitochondrial disease causes mutagenesis and depletion of mtDNA in Saccharomyces cerevisiae. Hum. Mol. Genet. 2010, 19, 2123-2133.
53. Di Re, M.; Sembongi, H.; He, J.; Reyes, A.; Yasukawa, T.; Martinsson, P.; Bailey, L.J.; Goffart, S.; Boyd-Kirkup, J.D.; Wong, T.S.; et al. The accessory subunit of mitochondrial DNA polymerase gamma determines the DNA content of mitochondrial nucleoids in human cultured cells. Nucleic Acids Res. 2009, 37, 5701-5713.
54. Walter, M.C.; Czermin, B.; Muller-Ziermann, S.; Bulst, S.; Stewart, J.D.; Hudson, G.; Schneiderat, P.; Abicht, A.; Holinski-Feder, E.; Lochmüller, H.; et al. Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2. J. Neurol. 2010, 257, 1517-1523.
55. Young, M.J.; Longley, M.J.; Li, F.Y.; Kasiviswanathan, R.; Wong, L.J.; Copeland, W.C. Biochemical analysis of human POLG2 variants associated with mitochondrial disease. Hum. Mol. Genet. 2011, 20, 3052-3066.
56. Tyynismaa, H.; Sembongi, H.; Bokori-Brown, M.; Granycome, C.; Ashley, N.; Poulton, J.; Jalanko, A.; Spelbrink, J.N.; Holt, I.J.; Suomalainen, A. Twinkle helicase is essential for mtDNA mainteinance and regulates mtDNA copy number. Hum. Mol. Genet. 2004, 13, 3219-3227.
57. Milenkovic, D.; Matic, S.; Kühl, I.; Ruzzenente, B.; Freyer, C.; Jemt, E.; Park, C.B.; Falkenberg, M.; Larsson, N.G. TWINKLE is an essential mitochondrial helicase required for synthesis of nascent D-loop strands and complete mtDNA replication. Hum. Mol. Genet. 2013, 22, 1983-1993.
58. Virgilio, R.; Ronchi, D.; Hadjigeorgiou, G.M.; Bordoni, A.; Saladino, F.; Moggio, M.; Adobbati, L.; Kafetsouli, D.; Tsironi, E.; Previtali, S.; et al. Novel Twinkle (PEO1) gene mutations in Mendelian progressive external ophthalmoplegia. J. Neurol. 2008, 255, 1384-1391.
59. Fratter, C.; Gorman, G.S.; Stewart, J.D.; Buddles, M.; Smith, C.; Evans, J.; Seller, A.; Poulton, J.; Roberts, M.; Hanna, M.G.; et al. The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO. Neurology 2010, 74, 1619-1626.
60. Hanisch, F.; Kornhuber, M.; Alston, C.L.; Taylor, R.W.; Deschauer, M.; Zierz, S. SANDO syndrome in a cohort of 107 patients with CPEO and mitochondrial DNA deletions. J. Neurol. Neurosurg. Psychiatry 2014, 86, 630-634.
61. Baloh, R.H.; Salavaggione, E.; Milbrandt, J.; Pestronk, A. Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle. Arch. Neurol. 2007, 64, 998-1000.
62. Kiferle, L.; Orsucci, D.; Mancuso, M.; Lo Gerfo, A.; Petrozzi, L.; Siciliano, G.; Ceravolo, R.; Bonuccelli, U. Twinkle mutation in an Italian family with external progressive ophthalmoplegia and parkinsonism: A case report and an update on the state of art. Neurosci. Lett. 2013, 27, 1-4.
63. Nikali, K.; Suomalainen, A.; Saharinen, J.; Kuokkanen, M.; Spelbrink, J.N.; Lönnqvist, T.; Peltonen, L. Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky. Hum. Mol. Genet. 2005, 14, 2981-2990.
64. Sarzi, E.; Goffart, S.; Serre, V.; Chrétien, D.; Slama, A.; Munnich, A.; Spelbrink, J.N.; Rötig, A. Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann. Neurol. 2007, 62, 579-587.
65. Kazachkova, N.; Ramos, A.; Santos, C.; Lima, M. Mitochondrial DNA damage patterns and aging: Revising the evidences for humans and mice. Aging Dis. 2013, 4, 337-350.
66. Alexeyev, M.; Shokolenko, I.; Wilson, G.; LeDoux, S. The maintenance of mitochondrial DNA integrity-Critical analysis and update. Cold Spring Harb. Perspect. Biol. 2013, 5, doi:10.1101/ cshperspect.a012641.
67. Akbari, M.; Morevati, M.; Croteau, D.; Bohr, V.A. The role of DNA base excision repair in brain homeostasis and diseases. DNA Repair 2015, doi:10.1016/j.dnarep.2015.04.029.
68. Prakash, A.; Doublié, S. Base Excision Repair in mitochondria. J. Cell. Biochem. 2015, 116, 1490-1499.
69. Zheng, L.; Zhou, M.; Guo, Z.; Lu, H.; Qian, L.; Dai, H.; Qiu, J.; Yakubovskaya, E.; Bogenhagen, D.F.; Demple, B.; et al. Human DNA2 is a mitochondrial nuclease/helicase for efficient processing of DNA replication and repair intermediates. Mol. Cell 2008, 32, 325-336.
70. Duxin, J.P.; Dao, B.; Martinsson, P.; Rajala, N.; Guittat, L.; Campbell, J.L.; Spelbrink, J.N.; Stewart, S.A. Human DNA2 is a nuclear and mitochondrial DNA maintenance protein. Mol. Cell Biol. 2009, 29, 4274-4282.
71. Gloor, J.W.; Balakrishnan, L.; Campbell, J.L.; Bambara, R.A. Biochemical analyses indicate that binding and cleavage specificities define the ordered processing of human Okazaki fragments by DNA2 and FEN1. Nucleic Acids Res. 2012, 40, 6774-6786.
72. Shim, E.Y.; Chung, W.H.; Nicolette, M.L.; Zhang, Y.; Davis, M.; Zhu, Z.; Paull, T.T.; Ira, G.; Lee, S.E. Saccharomyces cerevisiae Mre11/Rad50/Xrs2 and Ku proteins regulate association of Exo1 and DNA2 with DNA breaks. EMBO J. 2010, 29, 3370-3380.
73. Budd, M.E.; Campbell, J.L. DNA2 is involved in CA strand resection and nascent lagging strand completion at native yeast telomeres. J. Biol. Chem. 2013, 288, 29414-29429.
74. Ding, L.; Liu, Y. Borrowing nuclear DNA helicases to protect mitochondrial DNA. Int. J. Mol. Sci. 2015, 16, 10870-10887.
75. Shaheen, R.; Faqeih, E.; Ansari, S. Genomic analysis of primordial dwarfism reveals novel disease genes. Genome Res. 2014, 24, 291-299.
76. Steczkiewicz, K.; Muszewska, A.; Knizewski, L.; Rychlewski, L.; Ginalski, K. Sequence, structure and functional diversity of PD-(D/E)XK phosphodiesterase superfamily. Nucleic Acids Res. 2012, 40, 7016-7045.
77. Nicholls, T.J.; Zsurka, G.; Reeva, V.; Schoeler, S.; Szczesny, R.J.; Cysewski, D.; Reyes, A.; Kornblum, C.; Sciacco, M.; Moggio, M.; et al. Linear mtDNA fragments and unusual mtDNA rearrangements associate with pathological deficiency of MGME1 exonuclease. Hum. Mol. Genet. 2014, 23, 6147-6162.
78. Rampazzo, C.; Ferraro, P.; Pontarin, G.; Fabris, S.; Reichard, P.; Bianchi, V. Mitochondrial deoxyribonucleotides, pool sizes, synthesis, and regulation. J. Biol. Chem. 2004, 279, 17019-17026.
79. Pontarin, G.; Fijolek, A.; Pizzo, P.; Ferraro, P.; Rampazzo, C.; Pozzan, T.; Thelander, L.; Reichard, P.A.; Bianchi, V. Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage. Proc. Natl. Acad. Sci. USA 2008, 105, 17801-17806.
80. Jenuth, J.P.; Peterson, A.C.; Shoubridge, E.A. Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice. Nat. Genet. 1997, 16, 93-95.
81. Boschetti, E.; D'Alessandro, R.; Bianco, F.; Carelli, V.; Cenacchi, G.; Pinna, A.D.; del Gaudio, M.; Rinaldi, R.; Stanghellini, V.; Pironi, L.; et al. Liver as a source of thimidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy. PLoS ONE 2014, 9, e96692, doi:10.1371/journal.pone.0096692.
82. Scarpelli, M.; Ricciardi, G.K.; Beltramello, A.; Zocca, I.; Calabria, F.; Russignan, A.; Zappini, F.; Cotelli, M.S.; Padovani, A.; Tomelleri, G.; et al. The role of brain MRI in mitochondrial neurogastrointestinal encephalomyopathy. Neuroradiol. J. 2013, 26, 520-530.
83. Mancuso, M.; Salviati, L.; Sacconi, S.; Otaegui, D.; Camaño, P.; Marina, A.; Bacman, S.; Moraes, C.T.; Carlo, J.R.; Garcia, M.; et al. Mitochondrial DNA depletion: Mutations in thymidine kinase gene with myopathy and SMA. Neurology 2002, 59, 1197-1202.
84. Tyynismaa, H.; Sun, R.; Ahola-Erkkilä, S.; Almusa, H.; Pöyhönen, R.; Korpela, M.; Honkaniemi, J.; Isohanni, P.; Paetau, A.; Wang, L.; et al. Thymidine kinase 2 mutations in autosomal recessive progressive external ophtalmoplegia with multiple mitochondrial DNA deletions. Hum. Mol. Genet. 2012, 21, 66-75.
85. Alston, C.L.; Schaefer, A.M.; Raman, P.; Solaroli, N.; Krishnan, K.J.; Blakely, E.L.; He, L.; Craig, K.; Roberts, M.; Vyas, A.; et al. Late-onset respiratory failure due to TK2 mutations causing multiple mtDNA deletions. Neurology 2013, 81, 2051-2053.
86. Liu, Y.; Chen, X.J. Adenine nucleotide translocase, mitochondrial stress, and degenerative cell death. Oxid. Med. Cell. Longev. 2013, 2013, 146860, doi:10.1155/2013/146860.
87. Baines, C.P.; Song, C.X.; Zheng, Y.T.; Wang, G.W.; Zhang, J.; Wang, O.L.; Guo, Y.; Bolli, R.; Cardwell, E.M.; Ping, P. Protein kinase Cepsilon interacts with and inhibits thepermeability transition pore in cardiac mitochondria. Circ. Res. 2003, 92, 873-880.
88. Dörner, A.; Schultheiss, H.P. Adenine nucleotide translocase in the focus of cardiovascular diseases. Trends Cardiovasc. Med. 2007, 17, 284-290.
89. Jordens, E.Z.; Palmieri, L.; Huizing, M.; van den Heuvel, L.P.; Sengers, R.C.; Dörner, A.; Ruitenbeek, W.; Trijbels, F.J.; Valsson, J.; Sigfusson, G.; et al. Adenine nucleotide translocator 1 deficiency associated with Sengers syndrome. Ann. Neurol. 2002, 52, 95-99.
90. Tanaka, H.; Arakawa, H.; Yamaguchi, T.; Shiraishi, K.; Fukuda, S.; Matsui, K.; Takei, Y.; Nakamura, Y. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 2000, 404, 42-49.
91. Tyynismaa, H.; Ylikallio, E.; Patel, M.; Molnar, M.J.; Haller, R.G.; Suomalainen, A. A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophtalmoplegia with multiple mtDNA deletions. Am. J. Hum. Genet. 2009, 85, 290-295.
92. Pitceathly, R.D.S.; Smith, C.; Fratter, C.; Alston, C.L.; He, L.; Craig, K.; Blakely, E.L.; Evans, J.C.; Taylor, J.; Shabbir, Z.; et al. Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics. Brain 2012, 135, 3392-3403.
93. Ranieri, M.; Brajkovic, S.; Riboldi, G.; Ronchi, D.; Rizzo, F.; Bresolin, N.; Corti, S.; Comi, G.P. Mitochondrial fusion proteins and human diseases. Neurol. Res. Int. 2013, doi:10.1155/2013/293893.
94. Mishra, P.; Chan, D.C. Mitochondrial dynamics and inheritance during cell division, development and disease. Nat. Rev. Mol. Cell Biol. 2014, 15, 634-646.
95. Itoh, K.; Nakamura, K.; Iijima, M.; Sesaki, H. Mitochondrial dynamics in neurodegeneration. Trends Cell Biol. 2013, 23, 64-71.
96. Belenguer, P.; Pellegrini, L. The dynamin GTPase OPA1, more than mitochondria? Biochim. Biophys. Acta 2013, 1833, 176-183.
97. Jahani-Asl, A.; Pilon-Larose, K.; Xu, W.; MacLaurin, J.G.; Park, D.S.; McBride, H.M.; Slack, R.S. The mitochondrial inner membrane GTPase, optic atrophy 1 (OPA1), restores mitochondrial morphology and promotes neuronal survival following excitotoxicity. J. Biol. Chem. 2011, 286, 4772-4782.
98. Nguyen, D.; Alavi, M.V.; Kim, K.Y.; Kang, T.; Scott, R.T.; Noh, Y.H.; Lindsey, J.D.; Wissinger, B.; Ellisman, M.H.; Weinreb, R.N.; et al. A new vicious cycle involvingglutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell Death Dis. 2011, 2, doi:10.1038/cddis.2011.117.
99. Alexander, C.; Votruba, M.; Pesch, U.E.; Thiselton, D.L.; Mayer, S.; Moore, A.; Rodriguez, M.; Kellner, U.; Leo-Kottler, B.; Auburger, G.; et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 2000, 26, 211-215.
100. Delettre, C.; Lenaers, G.; Griffoin, J.M.; Gigarel, N.; Lorenzo, C.; Belenguer, P.; Pelloquin, L.; Grosgeorge, J.; Turc-Carel, C.; Perret, E.; et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 2000, 26, 207-210.
101. Hudson, G.; Amati-Bonneau, P.; Blakely, E.L.; Stewart, J.D.; He, L.; Schaefer, A.M.; Griffiths, P.G.; Ahlqvist, K.; Suomalainen, A.; Reynier, P.; et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: A novel disorder of mtDNA maintenance. Brain 2008, 131, 329-337.
102. Zanna, C.; Ghelli, A.; Porcelli, A.M.; Karbowski, M.; Youle, R.J.; Schimpf, S.; Wissinger, B.; Pinti, M.; Cossarizza, A.; Vidoni, S.; et al. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 2008, 131, 352-367.
103. Carelli, V.; Musumeci, O.; Caporali, L.; Zanna, C.; la Morgia, C.; del Dotto, V.; Porcelli, A.M.; Rugolo, M.; Valentino, M.L.; Iommarini, L.; et al. Syndromic parkinsonism and dementia associated with OPA1 missense mutations. Ann. Neurol. 2015, doi:10.1002/ana.24410.
104. Evgrafov, O.V.; Mersiyanova, I.; Irobi.; J.; van den Bosch, L.; Dierick, I.; Leung, C.L.; Schagina, O.; Verpoorten, N.; van Impe, K.; Fedotov, V.; et al. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat. Genet. 2004, 36, 602-606.
105. Vielhaber, S.; Debska-Vielhaber, G.; Peeva, V.; Schoeler, S.; Kudin, A.P.; Minin, I.; Schreiber, S.; Dengler, R.; Kollewe, K.; Zuschratter, W.; et al. Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion. Acta Neuropathol. 2013, 125, 245-256.
106. Löllgen, S.; Weiher, H. The role of Mpv17 protein mutations of which cause mitochondrial DNA depletion syndromes (MDDS): Lessons from homologs in different species. Biol. Chem. 2015, 396, 13-25.
107. Antonenkov, V.D.; Isomursu, A.; Mennerich, D.; Vapola, M.H.; Weiher, H.; Kietzmann, T.; Hiltunen, J.K. The human mtDNA depletion syndrome gene MPV17 encodes a non-selective channel that modulates membrane potential. J. Biol. Chem. 2015, 290, 13840-13861.
108. Spinazzola, A.; Viscomi, C.; Fernandez-Vizarra, E.; Carrara, F.; D'Adamo, P.; Calvo, S.; Marsano, R.M.; Donnini, C.; Weiher, H.; Strisciuglio, P.; et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat. Genet. 2006, 38, 570-576.
109. Garone, C.; Rubio, J.C.; Calvo, S.E.; Naini, A.; Tanji, K.; di Mauro, S.; Mootha, V.K.; Hirano, M. MPV17 mutations causing adult-onset multisystemic disorder with multiple mitochondrial DNA deletions. Arch. Neurol. 2012, 69, 1649-1651.
110. Blakely, E.L.; Butterworth, A.; Hadden, R.D.M.; Bodi, I.; Landping, H.; McFarland, R.; Taylor, R.W. MPV17 mutation causes neuropathy and leukoencephalopathy with multiple mtDNA deletions in muscle. Neuromuscol. Disord. 2012, 22, 587-591.
111. Mendelsohn, B.A.; Mehta, N.; Hameed, B.; Pekmezci, M.; Packman, S.; Ralph, J. Adul Onset Fatal Neurohepatopathy in a Woman Caused by MPV17 Mutation. JIMD Rep. 2014, 13, 37-41.
112. Wortmann, S.B.; Koolen, D.A.; Smeitink, J.A.; van den Heuvel, L.; Rodenburg, R.J. Whole exome sequencing of suspected mitochondrial patients in clinical practice. J. Inherit. Metab. Dis. 2015, 38, 437-443.
113. Garone, C.; Tadesse, S.; Hirano, M. Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. Brain 2011, 134, 3326-3332.
114. Tchikviladzé, M.; Gilleron, M.; Maisonobe, T.; Galanaud, D.; Laforêt, P.; Durr, A.; Eymard, B.; Mochel, F.; Ogier, H.; Béhin, A.; et al. A diagnostic flow chart for POLG-related diseases based on signs sensitivity and specificity. J. Neurol. Neurosurg. Psychiatry 2015, 86, 646-654.
115. Pareyson, D.; Saveri, P.; Sagnelli, A.; Piscosquito, G. Mitochondrial dynamics and inherited peripheral nerve diseases. Neurosci. Lett. 2015, 596, 66-77.
116. Lieber, D.S.; Calvo, S.E.; Shanahan, K.; Slate, N.G.; Liu, S.; Hershman, S.G.; Gold, N.B.; Chapman, B.A.; Thorburn, D.R.; Berry, G.T.; et al. Targeted exome sequencing of suspected mitochondrial disorders. Neurology 2013, 80, 1762-1770.
117. Calvo, S.E.; Compton, A.G.; Hershman, S.G.; Lim, S.C.; Lieber, D.S.; Tucker, E.J.; Laskowski, A.; Garone, C.; Liu, S.; Jaffe, D.B.; et al. Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci. Transl. Med. 2012, 4, doi:10.1126/scitranslmed.3003310.